Clark George C.

VP, Chief Accounting Officer at Biohaven Pharmaceutical Holding Co Ltd.

Sold, on record
$1.9M
Dollars the filings state
Form 4 sales
3
Latest May 10, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not stated
    Dec 20, 2021 2021

    Sold 1,915 shares at $123.84 ($237k)

    Clark George C., VP, Chief Accounting Officer

    Sold 18.9% of holdings ($1.3M position)8,240 shares leftFirst sale on recordFiling

  2. Jan 19, 2022 +30 days

    Sold 9,375 shares at $117.01 ($1.1M)

    Clark George C., VP, Chief Accounting Officer

    Sold 60.9% of holdings ($1.8M position)6,015 shares leftFiling

  3. May 10, 2022 +111 days

    Sold 4,200 shares at $141.50 ($594k)

    Clark George C., VP, Chief Accounting Officer

    Sold 50.8% of holdings ($1.2M position)4,065 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Clark George C.
Source
May 10, 2022May 12, 2022Biohaven Pharmaceutical Holding Co Ltd.VP, Chief Accounting OfficerForm 4 sale4,200$594k50.8%UnusualSEC
Jan 19, 2022Jan 24, 2022Biohaven Pharmaceutical Holding Co Ltd.VP, Chief Accounting OfficerForm 4 sale9,375$1.1M60.9%UnusualSEC
Dec 20, 2021Dec 22, 2021Biohaven Pharmaceutical Holding Co Ltd.VP, Chief Accounting OfficerForm 4 sale1,915$237k18.9%Plan not statedSEC